Akouos
Manufacturing · Massachusetts, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
645 Summer St Ste 200, Boston, Massachus...Phone Number
(857) 410-1818Website
www.akouos.comRevenue
$34.8 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
3
2
1
1
1
1
About Akouos
Akouos is a precision genetic medicine company dedicated to developing gene therapies with the potential to restore, improve, and preserve high-acuity physiologic hearing for individuals living with disabling hearing loss worldwide. Leveraging its precision genetic medicine platform that incorporates a proprietary adeno-associated viral (AAV) vector library and a novel delivery approach, Akouos is focused on developing precision therapies for forms of sensorineural hearing loss. Headquartered in Boston, Akouos was founded in 2016 by leaders in the fields of neurotology, genetics, inner ear drug delivery, and AAV gene therapy.Explore more
Akouos Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Akouos your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Akouos launches new products
Funding: Get notified immidiatlly once Akouos has new funding data
Earning: See what the market has to say on Akouos recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Akouos
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Akouos, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Akouos has recently received funding, and reach out quickly before it becomes old news!
Check out if Akouos is spiking on competitors!
Click to see if Akouos had a recent Job posting/layoffs
Recommended Actions
Find VP level buyers at Akouos
Find 3 more new buyers
Compare Similar Companies to Akouos
Compare insights from companies similar to Akouos, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Akouos is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Akouos is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Akouos.
Akouos financials insights
Gather financial insights about Akouos, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2018
Series A
$50M
2020
Series B
$105M
Stock Offering
$213M
Akouos Tech Stack
A closer look at the technologies used by Akouos
Most Recent Scoops
Partnership
Project
Laboratory Operations, Medical Research, Clinical Operations
Partnership
Project
Laboratory Operations, Medical Research, Clinical Operations
Partnership
Project
Laboratory Operations, Medical Research, Clinical Operations
Event
Events
Left Company
Executive Move
Akouos News & Media
Lilly Completes Acquisition of Akouos Expanding Efforts to Help People with Genetic Diseases
INDIANAPOLIS, Dec. 1, 2022 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced the successful completion of its acquisition of Akouos, Inc. (NASDAQ: AKUS). The acquisition expands Lilly's efforts in genetic medicines to include Akouos's portfolio of potential first-in-class...Lilly and Akouos Announce Expiration of Akouos Tender Offer
INDIANAPOLIS and BOSTON, Nov. 30, 2022 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and Akouos, Inc. (NASDAQ: AKUS) today announced that the tender offer to purchase all of the issued and outstanding shares ("Shares") of Akouos's common stock in exchange for (a) $12.50 per Share, net...Akouos Reports Third Quarter 2022 Financial Results and Provides Business Highlights
BOSTON, Nov. 14, 2022 (GLOBE NEWSWIRE) — Akouos, Inc. (NASDAQ: AKUS), a precision genetic medicine company dedicated to developing potential gene... Read More The post Akouos Reports Third Quarter 2022 Financial Results and Provides Business Highlights appeared first on citybiz.INVESTOR ALERT: The M&A Class Action Firm Announces the Investigation of Akouos, Inc. - AKUS
NEW YORK, Oct. 24, 2022 /PRNewswire/ -- Juan Monteverde, founder and managing partner of the class action firm Monteverde & Associates PC (the "M&A Class Action Firm"), a national securities firm rated Top 50 in the 2018-2021 ISS Securities Class Action Services Report and headquartered...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Akouos
Sign Up For FreeTo access detailed company insights
Akouos is a precision genetic medicine company dedicated to developing gene therapies with the potential to restore, improve, and preserve high-acuity physiologic hearing for individuals living with disabling hearing loss worldwide. Leveraging its precision genetic medicine platform that incorporates a proprietary adeno-associated viral (AAV) vecto... Read More
